Skip to content
Stock screener

RVTY Revvity, Inc. stock chart & analysis

Conviction 38HealthcareScan · Fri, Nov 6, 2026

Revvity, Inc. (RVTY) closed at $155.11 (+2.84%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 96, -9.7% from its 52-week high, +60.4% year to date. Sector: Healthcare · Laboratory Analytical Instruments.

RVTY$155.11+2.84%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Revvity, Inc.Laboratory Analytical Instrumentswww.revvity.com ↗
Price155.11
Change+2.84%
Gap+0.03%
Rel volume0.74×
Avg volume1.9M
Avg $ vol298.92M
SMA 20157.04
SMA 50147.52
SMA 200112.91
Price vs 50+5.18%
Price vs 200+37.41%
MA stackbullish
50/200 cross—
Supertrendup · 148.10
RSI (14)51
MACD hist-1.33
MACD crossbear · 5d
Stoch %K / %D25 / 23
ADX (14)28
+DI / −DI22 / 25
RSI divergence—
MACD divergence—
ATR %5.02%
ADR %4.25%
52w high171.74
52w low81.22
From 52w high-9.65%
Above 52w low+91.04%
New 52w highNo
SqueezeOn · 4d
Bollinger width11.32%
%B0.39
Donchian pos27.63%
Donchian high171.74
Donchian low148.83
AVWAP (52w high)159.95
vs AVWAP high-2.99%
AVWAP (52w low)125.14
vs AVWAP low+23.99%
OBV trendFlat
Chaikin MF (20)-0.24
Today vs 20d0.74×
Avg vol (14d)2.04M
Avg vol (20d)1.9M
Avg $ vol (20d)298.92M
Market cap17.31B
RS Rating96 / 99
RS 3m (vs SPY)+38.60%
RS 6m (vs SPY)+53.92%
RS line new highNo
Trend template8/8
Technical rank86.4
1 week-1.17%
1 month+1.97%
3 months+33.74%
6 months+53.62%
1 year+67.61%
YTD+60.37%
P/E71.78
P/B2.40
P/S6.06
P/FCF33.99
EPS2.07
Div yield0.19%
ROE3.34%
ROA2.00%
Debt/Eq0.44
Current1.80
EV/EBITDA25.59
Gross margin—
Net margin8.45%
Rev growth3.67%
EPS growth-10.79%
Price target166.85
Target upside7.53%
Analyst ratingHold
Institutional123.33%
Ent. value19.5B
Revenue729.69M
Net income51.82M
Gross profit416.87M
Free cash flow509.41M
IndustryLaboratory Analytical Instruments
ExchangeNYSE
Shares out111.56M
Employees11K
ListedThu, Jun 1, 1972
Free float111.32M
Float %99.6%
Short interest—
Days to cover—
Short volume47.4%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$1.38 vs $1.29
Last surprise+7.0% beat
Setup gradeD
Conviction38 / 100
Pattern quality—
Tech rank86.4 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance170.40
Support143.39
Days since event—
Candle confirm—

Financials as of Sun, Jul 5, 2026 · quarterly.

RVTY technical analysis

Trend

RVTY is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 5.2% above the 50-day ($147.52) and 37.4% above the 200-day ($112.91). ADX(14) at 28 points to a strong, established trend. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 51, in the bullish half of its range. MACD crossed below its signal line 5 sessions ago. Its RS Rating of 96 puts its weighted 12-month performance ahead of about 96% of the US market.

Volume and volatility

Volume on the latest session ran 0.7× its 20-day average. It trades about $298.9M a day on average. ATR(14) is $7.79, 5.0% of price — its typical daily range. Bollinger Bands are in a squeeze (4 sessions) — volatility is compressed. Chaikin Money Flow (-0.24) shows distribution.

Key levels

The chart pattern's support is $143.39 and its resistance $170.40. The 52-week range is $81.22 to $171.74; price is 9.7% below the high and 91.0% above the low. The VWAP anchored at the 52-week high is $159.95, above price.

Performance

RVTY returned -1.2% (1 week), +2.0% (1 month), +33.7% (3 months), +53.6% (6 months), +67.6% (1 year), +60.4% (year to date).

About Revvity, Inc.

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Laboratory Analytical Instruments · Listed 1972 · 11,000 employees

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 18
    1 scan
  2. Breaking out now
    Aug 19
    1 scan

Congress activity

Disclosed STOCK Act trades in RVTY · 10 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-09-04
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-09-03
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-09-09
Sell$15K–$50K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-04
Buy≥ $15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-01
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-09-12
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-13
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-07-23
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-07-22
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in RVTY · open-market 1 sell

InsiderSideShares
MICHAS ALEXIS P
Director · Common Stock · 2026-08-25
Gift285
Goldberg Joel S
Please See Remarks · Common Stock · 2026-08-14
Gift27.79K
Goldberg Joel S
Please See Remarks · Common Stock · 2026-08-14
Gift27.79K
Singh Prahlad R.
Please See Remarks · Common Stock · 2026-08-13
Gift7.64K
Singh Prahlad R.
Please See Remarks · Common Stock · 2026-08-13
Gift7.64K
Singh Prahlad R.
Please See Remarks · Common Stock · 2026-08-13
Gift59.65K
Singh Prahlad R.
Please See Remarks · Common Stock · 2026-08-13
Gift59.65K
Gonzales Anita
Vice President and CAO · Common Stock · 2026-07-20
Sell85
Chapin Samuel R.
Director · Common Stock · 2026-05-07
Grant1.26K
McMurry-Heath Michelle
Director · Common Stock · 2026-05-07
Grant1.01K

SEC filings

EDGAR filings in RVTY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.